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Abstract
Cigarette smokers and those exposed to second hand smoke are more susceptible to life threatening infection than non-
smokers. While much is known about the devastating effect tobacco exposure has on the human body, less is known about
the effect of tobacco smoke on the commensal and commonly found pathogenic bacteria of the human respiratory tract, or
human respiratory tract microbiome. Chronic rhinosinusitis (CRS) is a common medical complaint, affecting 16% of the US
population with an estimated aggregated cost of $6 billion annually. Epidemiologic studies demonstrate a correlation
between tobacco smoke exposure and rhinosinusitis. Although a common cause of CRS has not been defined, bacterial
presence within the nasal and paranasal sinuses is assumed to be contributory. Here we demonstrate that repetitive tobacco
smoke exposure induces biofilm formation in a diverse set of bacteria isolated from the sinonasal cavities of patients with CRS.
Additionally,bacteriaisolatedfrompatients with tobaccosmoke exposuredemonstraterobust invitro biofilm formationwhen
challenged with tobacco smoke compared to those isolated from smoke naı ¨ve patients. Lastly, bacteria from smoke exposed
patientscanrevertto a non-biofilmphenotypewhengrown inthe absence of tobacco smoke. Theseobservations supportthe
hypothesis that tobacco exposure induces sinonasal biofilm formation, thereby contributing to the conversion of a transient
and medically treatable infection to a persistent and therapeutically recalcitrant condition.
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Introduction
Chronic rhinosinusitis (CRS) represents a spectrum of inflam-
matory and infectious processes concurrently affecting the nose
and paranasal sinuses [1]. Recent reviews reported an estimated
prevalence in the United States of 16% with an aggregated annual
cost of nearly $6 billion [2,3]. CRS patients may have significant
decrements in quality of life, both in disease specific areas and in
general health. In fact, patients requiring sinus surgery demon-
strate worse scores for physical pain and social functioning than
those suffering from chronic obstructive pulmonary disease,
congestive heart failure, back pain, or angina [4].
A broad range of factors can contribute to the evolution of CRS
symptoms. For example, inherent mucociliary defects such as
those found in patients with cystic fibrosis or primary ciliary
dyskinesia [5,6], abnormal innate immunity [7], paranasal sinus
anatomic variations [8,9], environmental exposure [10], allergy,
[11,12] and microbial colonization [13,14] have all been
associated with CRS. Recently, multiple investigations have
highlighted a possible role of bacterial biofilms in the persistence
of chronic infections including CRS [15,16,17,18,19,20].
Bacterial biofilms comprise a complex, organized community of
bacteria that attach to both biotic and abiotic surfaces [21].
Biofilm-forming bacteria are thought to begin as independent,
planktonic bacteria which become sessile and initiate biofilm
formation by adhering to a surface and forming microcolonies.
When a critical density of bacteria is reached, intra- and inter-
bacterial species cross-talk begins through a process commonly
referred to as quorum sensing, which comprises changes in gene
expression and post-translational modification of proteins that
ultimately lead to expression of the biofilm phenotype [22,23].
This phenotype is characterized morphologically by the formation
of microbial ‘towers’ that are composed of layers of embedded, live
bacteria with intervening water channels, and a ‘mortar’ for these
structures composed of bacterially produced exopolymeric matrix
(carbohydrates, proteins and nucleic acids), making up as much as
90% of the biofilm volume.[24] Biofilms allow for the evasion of
host defenses, decreased susceptibility to antibiotic therapy, and
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implantation and colonization of new anatomic locations thereby
causing nascent acute infections in the host [25].
In addition to genetic, anatomic, environmental and microbial
contributions to the development of CRS, the specific environ-
mental exposure to tobacco smoke has also been suggested as a
risk factor for the ‘‘aggravation and prolongation of sinusitis’’ as far
back as 1964 in the Surgeon General’s report on smoking [26].
Several epidemiologic studies have demonstrated a higher
prevalence of CRS in cigarette smokers as compared to non-
smokers [27,28]. Additionally, studies have evaluated the role of
tobacco smoke exposure on outcomes of functional endoscopic
sinus surgery (FESS) and demonstrated higher surgical revision
rates and more frequent bouts of post surgical rhinosinusitis in
smokers compared to non-smokers [29,30,31,32]. While the
detrimental effects of tobacco smoke exposure on the respiratory
epithelium are well described [33,34,35,36], the effects of tobacco
smoke exposure on biofilm formation in bacteria from the
paranasal sinuses has not been investigated.
Here, we report that repetitive in vitro exposure to whole tobacco
smoke induces biofilm formation in bacteria isolated from the
sinonasal cavities of patients with CRS. Additionally, bacteria
isolated from patients with tobacco exposure demonstrate robust
biofilm formation when challenged with tobacco smoke in vitro
compared to bacteria isolated from smoke naı ¨ve patients. Lastly,
bacteria from smoke exposed patients can revert to a non-biofilm
phenotype when grown in the absence of tobacco smoke. The
implication of our data is that smoke exposure in vivo induces
alterations in the bacterial life cycle resulting in resistance to both
host defenses as well as conventional antimicrobial therapy leading
to a persistent infection that is much more difficult to treat.
Furthermore, these findings have important ramifications not only
for CRS, but for numerous other respiratory tract infection
including otitis media, chronic obstructive pulmonary disease,
bronchitis, and pneumonia.
Materials and Methods
Specimen collection
Approval was obtained from the University of Pennsylvania
Institutional Review Board to enrol adult patients who met the
objective and subjective guidelines for CRS, set forth by the Sinus
and Allergy Health Partnership [37] and written consent was
obtained from all patients participating in the study. Sinonasal
cultures were obtained from CRS patients with mucopurulent
sinonasal secretions. Participants in this study were solicited from
patients undergoing evaluation for CRS at the University of
Pennsylvania, Department of Otorhinolaryngology – Head and
Neck Surgery. Subjects were consenting adults (both male and
female) over the age of 18 years. Exclusion criteria included
rhinologic granulomatous disease, cystic fibrosis, immune defi-
ciencies or other genetic disorders that may directly affect
mucociliary function such as primary ciliary dyskinesia. Patients
were stratified based on past or present tobacco use, and whether
or not each lived with a smoker. Duplicate sinonasal culture swabs
were obtained under endoscopic guidance and performed either in
the outpatient clinic setting, or during endoscopic sinus surgery.
One bacterial swab was sent for microbiologic characterization
and antibiotic sensitivities to the clinical microbiology laboratory
and the other swab was placed in Luria-Bertani (LB) broth and
grown overnight at 37uC. Following overnight growth, an
additional bacterial swab of the resultant culture was obtained
and sent for microbiologic characterization by the clinical
microbiology laboratory by standard techniques. Commercially
available strains P. aeruginosa (PAO1) and Staphylococcus aureus 29213
were purchased from ATCC.
Biofilm quantification
Quantification of biofilm formation was performed as previ-
ously described [38]. Briefly, bacterial strains isolated from
different patients, as well as the control strains, were grown
overnight in 100% LB broth Luria- Bertani (LB) broth (Fisher
Scientific, Hanover Park, Illinois, USA) at 37uC. The following
morning cultures were diluted to an optical density of 600 nm
(OD600) =0.1 and subsequently diluted (distilled water) 1:100 in
50% LB broth, resulting in a final testing inoculum of ,10
6 CFU.
One hundred fifty-ml of the freshly diluted culture was placed in
octuplet in two flat-bottomed 96-well plates (Costar-Corning,
Sigma-Aldrich Corp. St. Louis, MO, USA), one for tobacco
exposure and one for sham exposure (see below). Biofilms were
grown and quantified as previously reported [39,40]. Briefly,
following tobacco or sham exposure, bacteria were incubated in
the 96-well plates for 20 h at 37uC. After incubation, the contents
of each well were decanted and washed three times with 200 mlo f
sterile phosphate-buffered saline solution using a multichannel
micropipette to remove all non-adherent bacteria but preserving
the formed biofilm [38]. The remaining attached bacteria were
heat-fixed by incubating at 60uC for 60 min. Subsequent
quantification of biofilm was performed using the modified
Christensen’s method [41]. Each well of the 96 wells plate was
filled with 150 ml 10% crystal violet (Harleco, Gibbstown, NJ), and
incubated for 30 min at room temperature. The wells were then
decanted and the excess dye was rinsed by placing the plate under
running tap water until the water was clear. The dye bound to the
adherent material was resolubilized and eluted with 150 ml of 95%
ethanol per well at room temperature for 30 minutes, without
shaking. Finally, the OD595 nm of the ethanol elutions was
determined using a BioRad 680 plate reader (Hercules, Califor-
nia). Each experiment was repeated a minimum of two times.
In vitro smoke exposure
Freshly diluted cultures were placed with the lid off into an
airtight box (20 cm (l)620 cm (w)615 cm (h)) with an inflow port
at the top center, and a diffuser midway between the inflow port
and the 96-well plate. Tobacco smoke was generated as previously
described [35]. Briefly, standardized research cigarettes 1R5F
(Tobacco and Health Research Institute, University of Kentucky)
were ignited in an automated smoking machine (Teague TE-10,
Teague Enterprises, Davis, CA), that was programmed to take a
2 s, 35 ml puff from the burning cigarette every 60 s. A total of
five cigarettes were burned with the ‘‘inhaled’’ smoke being
directly pumped into the exposure box. Bacteria were exposed to
tobacco smoke for 3 h and then incubated in a designated 37uC
‘‘smoke’’ incubator. Sham exposed cells were placed in similar
boxes (albeit never having been used for tobacco smoke exposure)
with room air being vented in a similar fashion. After 3 h, sham-
exposed plates were incubated in a separate incubator. Following
17 h of recovery, plates were processed as described above to score
them for biofilm formation. Each experimental condition was
performed a minimum of two times.
In vitro chronic smoke exposure
Twenty hours after the initial exposure 50 ml of each strain from
both the sham exposed and tobacco-exposed plates were removed
and diluted 1:100 in 50% LB broth. One hundred and fifty mlo f
the freshly diluted cultures were transferred to a new sterile flat-
bottomed 96 wells plate for subsequent tobacco or sham exposure
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designated time course.
Data Analysis
Data were expressed as mean 6 standard deviation. Mann-
Whitney U test and the chi-square test were done in order to
analyze the relationship among variables and for the comparison
of means and proportions. One way ANOVA, Kruskal-Wallis test
and Dunn’s Multiple Comparison Test were performed to analyze
‘‘phenotypic switch’’. Differences were considered statistically
significant when p,0.05.
Results
Biofilm formation in the absence or presence of
exogenous tobacco smoke
To evaluate the degree to which tobacco smoke impacts biofilm
formation, bacterial cultures were obtained from CRS patients,
with and without tobacco exposure, demonstrating mucopurulent
sinonasal secretions on nasal endoscopic exam. Culture swabs
were obtained with endoscopic guidance and placed in appropri-
ate media and grown overnight followed by microbial identifica-
tion tests and biofilm formation assays. Taxonomical identity and
source of the isolates is shown in Table 1. In addition to the clinical
strains, commercially available strains of Pseudomonas aeruginosa (Pa)
(PAO-1) and Staphyloccocus aureus (Sa) (29213) were used as positive
controls for biofilm formation and to evaluate the effect of tobacco
exposure on non-clinical isolates.
To determine whether the bacterial biofilm formation was
altered by acute exposure to tobacco smoke, bacteria from either
smoke-exposed patients or smoke-naı ¨ve patients were either sham
or tobacco smoke challenged for three hours before undergoing
the biofilm formation assay. Figure 1 demonstrates that acute
smoke exposure significantly increased biofilm formation in 12 of
16 clinical isolates from smokers, but 0 of 18 isolates from non-
smokers (* p,0.05). Because each isolate served as its own control,
the ratio of biofilm formation (OD595 smoke/sham) represents
induction of biofilm formation when greater than 1 or inhibition of
biofilm formation when less than 1. Ex vivo smoke exposure of
bacteria obtained from smokers’ sinuses resulted in significantly
more induction of biofilm formation (ratio of 1.7560.31) than that
seen in bacteria from nonsmokers’ sinuses, in which ex vivo smoke
exposure inhibited biofilm formation (ratio of 0.6360.23) (figure 2,
p,0.001). To determine whether the in vivo quantity of tobacco
smoke exposure impacted on in vitro biofilm formation we
evaluated tobacco exposure, as self reported by the patients in
pack year history, to biofilm formation which revealed no
correlation (r
2=0.098) (data not shown).
Biofilm formation after repetitive smoke exposure
Because a single smoke exposure resulted in opposite effects on
biofilm formation in bacteria isolated from smoke naı ¨ve patients
vs. smoke-exposed patients, we hypothesized that chronic or
repetitive smoke exposure would alter the biofilm forming capacity
of bacteria. To test this hypothesis, we exposed bacterial cultures
obtained from smoke naı ¨ve patients to smoke or sham daily (5
cigarettes over 3 h), for 4 days. Biofilm formation was tested
17 hours following each exposure. In support of our hypothesis, all
14 of the clinical isolates tested had a biofilm formation ratio of less
than 1 after the first smoke exposure, but had a ratio greater than
Table 1. Bacterial isolates used in this work.
Non-Smokers Smokers
ID Biofilm Cx Clinical Cx PY ID Biofilm Cx Clinical Cx PY
1535 S. aureus S. aureus
P. vulgaris
None 1176 K. oxytoca K. oxytoca,
C. freundii
60
1580 P. aeruginosa P. aeruginosa None 1620 S. pneumoniae S. pneumoniae 80
1662 S. aureus S. aureus None 1670 P. vulgaris P. vulgaris
S. pneumoniae
8
1750 S. aureus S. aureus None 1675 S. aureus S. aureus 25
1751 K. oxytoca K. oxytoca
S. liquifaciens
None 1690 S. aureus S. aureus SHS
1752 S. marcescens S. marcescens None 1695 S. aureus S. aureus 7
1754 K. pneumoniae K. pneumoniae P. vulgaris None 1696 E. coli E. coli 12
1756 S. pneumoniae S. pneumoniae None 1843 S. aureus S. aureus 10
1759 S. aureus S. aureus None 1848 K. pneumoniae K. pneumoniae
CNS
30
1760 CNS CNS None 1851 S. pneumoniae S. pneumoniae
CNS
18
1764 CNS Enterococcus None 1854 P. aeruginosa P. aeruginosa 35
1772 P. vulgaris P. vulgaris None 1880 K. pneumoniae K. pneumoniae 25
1775 S. aureus S. aureus None 1924 P. aeruginosa P. aeruginosa 5
1779 K. pneumoniae K. pneumoniae CNS None 1951 S. aureus S. aureus 12
1781 S. marcescens CNS None 2008 S. aureus S. aureus 10
2001 P. aeruginosa P. aeruginosa None 2033 S. aureus S. aureus 3
Culture result represents the bacterial isolate recovered from the initial Clinical culture or resultant from the Biofilm culture. Tobacco exposure is expressed a packs of
cigarettes smoked per day X years smoking (PY). One patient, #1690, lived with a smoker and was thus designated as second hand smoker (SHS). CNS: Coagulase
negative Staph.
doi:10.1371/journal.pone.0015700.t001
Tobacco Smoke Induces Microbial Biofilms
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e157001 by the fourth exposure (figure 3). In 10 of 14 clinical bacterial
isolates and the two commercial controls (P. aeruginosa and S. aureus)
showed a fast shift from tobacco induced biofilm inhibition (values
,1) to tobacco induced biofilm formation (values .1) following
the second day of smoke exposure (*) whereas the other three
bacterial cultures required three (#) or four days of smoke
exposure ($) (figure 3).
The converse of our hypothesis is that bacteria from smokers’
sinuses when removed from the stimulus of cigarette smoke revert
to a phenotype similar to that seen in bacteria from nonsmokers.
To test this possibility, we grew bacterial isolates from smokers in
the absence of tobacco smoke for 4 days. On the fifth day we
exposed them to tobacco smoke (5 cigarettes/3 h) and assessed the
effect on biofilm formation 17 h later, similar to the experiments
demonstrated in figure 1. In contrast to the data presented in
figure 1, 12 of 17 clinical isolates from smokers had significant
cigarette smoke inhibition of biofilm formation after growth in the
absence of smoke for several days (figure 4).
Discussion
The World Health Organization estimates that tobacco use
accounts for 3% of the world’s morbidity and mortality at a cost of
tens of billions of U.S. dollars annually [42]. Although tremendous
strides have been made in curtailing cigarette consumption, the
prevalence of smoking among adults and children in the US
remains approximately 22-24%, translating to an estimated
66,000,000 people who smoke regularly [42]. While much is
known about the adverse effects of tobacco exposure on human
physiology, relatively less is known about the effect of tobacco
smoke on the respiratory tract microbiome. Recent work has
demonstrated that cigarette smokers and those exposed to second
hand smoke are more susceptible to life-threatening infection than
non-smokers [33] and that smoking is an independent risk factor
for pneumococcal pneumonia, Legionnaire’s disease, periodontal
disease, and meningococcal disease, among others [33,43,44].
CRS is a disease of unknown etiology which affects more than
35 million Americans of all ages resulting in over 500,000 surgeries
Figure 1. Biofilm formation in bacteria obtained from endoscopically guided sinonasal cultures, following sham or tobacco smoke
exposure. Samples from patients evaluated in the outpatient clinic or in the operating room, who were found to have sinonasal mucopurulence
were cultured. Samples were grown overnight and subjected to evaluation for biofilm forming capacity. A three hour tobacco smoke exposure
(resultant from five cigarettes). Each isolate was performed in octuplet. A paired Student t-test was applied to compare smoke and sham exposed
(*=p,0.01).
doi:10.1371/journal.pone.0015700.g001
Figure 2. Tobacco biofilm index. Data from figure 1A was
normalized by creating a ratio of smoke to sham exposed biofilm
formation. Value of ,1 demonstrates biofilm inhibition while value .1
reflects biofilm induction.
doi:10.1371/journal.pone.0015700.g002
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decrements in quality of life, both in disease specific areas and in
general health. In fact, patients requiring sinus surgery demon-
strate worse scores for physical pain and social functioning than
those suffering from chronic obstructive pulmonary disease,
congestive heart failure, back pain, or angina [4]. This disease is
most likely not one disorder, but rather represents a number of
discrete entities and pathologies. Regardless of the underlying
etiology, multiple reports have correlated tobacco smoke exposure
with increased prevalence of CRS and poor sinus surgery
outcomes [27,28,46]. The contributory mechanisms of tobacco
smoke exposure to this disease process have predominately focused
on its detrimental effects on the respiratory epithelium
[34,35,36,47,48] and immune system [33,49,50,51], but relatively
less is known about the effect of tobacco smoke on the bacteria that
reside in the sinonasal cavity which are felt to contribute directly to
the pathogenesis of CRS.
A primary function of the nasal cavity is to humidify and cleanse
inspired air. This is accomplished by creating transitional air flow
(partially laminar and partially turbulent) which promotes the
deposition of particulate matter in the sinonasal mucus blanket
[52]. Thus, the nose and paranasal sinuses (especially in the post
surgical cavity) are exposed to significantly higher concentrations
of particulate environmental pollutants than are the lower airways
[53]. Recently, multiple investigations have highlighted a possible
role of sinonasal mucosa bacterial biofilms in persistent recalcitrant
CRS [15,16,17,18,19,20]. Thus, the effect of tobacco smoke on
the ability to form biofilms was assessed in bacterial cultures
obtained from smokers and smoke naı ¨ve CRS patients.
Utilizing endoscopically guided sinonasal microbial swabs from
CRS patients with and without tobacco smoke exposure we
assembled a battery of 34 microbial cultures (18 smoke naı ¨ve, 16
smoke exposed) (Table 1), which are representative of the
microbes isolated from patients with CRS [18,19,54]. We are
aware that the subsequent culturing protocol, i.e., overnight
growth in broth prior to the smoke exposure, most likely selected
for specific microbes and thus may not be fully reflective of the in
vivo microbial milieu. We did not see a difference between the non-
smokers and smokers in the bacteria cultured from the initial
sinonasal swab nor the resultant bacteria of the biofilm cultures
Figure 3. Biofilm formation after repetitive smoke exposure. Bacteria isolated from smoke naı ¨ve patients were subjected to daily sham or
smoke exposure (5 cigarettes/3 h) and then subjected to the biofilm detection assay. Data is represented as the ratio of smoke exposure to sham
exposure. *, #, and $ indicate significant differences (p,0.05) between day 1 and 2, day 1 and 3, and day 1 and 4, respectively. Indicate the number of
replicates.
doi:10.1371/journal.pone.0015700.g003
Figure 4. Smoke induced biofilm formation is reversible. Bacteria isolated from smokers were grown for 4 days in the absence of tobacco
smoke, before a single sham or smoke exposure (5 cigarettes/3 h) and subsequent biofilm detection assay. Indicate the number of replicates, and
repeat the significance test performed, and the p values.
doi:10.1371/journal.pone.0015700.g004
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concordance between the initial clinical swab and the resultant
biofilm culture. In four samples from smokers and four samples
from non-smokers, the initial clinical cultures yielded more than
one organism but the resultant biofilm culture only yielded one
organism. Of the samples with multiple organisms identified, the
second organism that did not propagate to the biofilm was
coagulase negative staph (n=3), P. vulgaris (n=2), S. liquifaciens
(n=1), C. freundii (n=1), and S. pneumoniae (n=1). While Brook
noted more pathogens recovered in nasopharyngeal swabs of
smokers compared to non-smokers [55], in our CRS population
we did not see a difference between cohorts. Furthermore, while
many experimental paradigms investigating the role of tobacco
exposure on biological processes utilize either cigarette smoke
condensate [56] or cigarette smoke extract [44], we utilized whole
cigarette smoke, as previously described [35], to better represent
microbial in vivo exposure.
Our results clearly demonstrate that immediately following
removal, bacterial isolates from smokers were more prone to
produce biofilm material in response to smoke exposure than those
from non-smokers, but that the latter group strongly enhances its
ability to produce biofilms when repetitively exposed to smoke in
vitro. Importantly, growth of the bacterial isolates from smokers in
the absence of tobacco smoke produced a biofilm formation
phenotype characteristic of the bacterial isolates from non-smokers
(figure 4), suggesting reversibility of the tobacco effect and further
supporting the notion that encouraging people to stop smoking has
immediate positive health effects. Moreover, these phenotypic
switches fostered by tobacco smoke exposure or removal, were not
identified in a single organism but rather in more than eight
different species. Therefore, we speculate that these responses
represent a well-conserved, global microbial response to tobacco
smoke exposure and could possibly represent a novel therapeutic
target.
In fact, recent evidence suggests that smoking uptake and
cessation can alter microbial communities [43,57]. Although the
exact mechanism(s) have not been elucidated, studies have
demonstrated that cigarette smoke alters gene expression in
microbial pathogens [44,50]. For example, Bagaitkar et al used a
whole genome microarray of Porphyromonas gingivalis to demonstrate
that exposure of bacteria to cigarette-smoke conditioned medium
caused differential expression of 6.8% of the P. gingivalis genome,
including increase expression of virulence factors, alteration of
expression of membrane proteins, and differential expression of
oxidative stress genes [44].
Notably, evaluation of tobacco exposure, as self-reported by the
patients in pack year history, did not correlate with the smoke
induced biofilm formation (r
2=0.098) (data not shown). This may
be due to poor patient history, as studies have demonstrated that
self-reported personal history is not always reliable as a means of
screening for smoking [58,59]. However, another possibility may
be that smoke induced biofilm formation is triggered by a
threshold exposure and is not a dose dependent phenomenon.
Our data was generated by whole tobacco smoke and thus is
especially pertinent to the upper airways and possibly the lower
airways, though certain caveats must be acknowledged. First, we
chose empirically to expose bacteria to the smoke of 5 cigarettes
over 3 hours with each cigarette being drawn by a 35-ml, 2-s puff
once per min for 10 min. We chose this amount using the logic
that a 1 pack per day smoker who smokes during 12 hours of the
day will consume approximately 1.5 cigarettes per hour on
average. This degree of exposure is most likely an exaggeration of
in vivo sinonasal exposure, particularly as we did not ventilate the
exposure chamber for three hours. Additionally, we did not vary
the exposure time or dose to determine the threshold necessary for
biofilm induction. Finally, we did not attempt to fractionate whole
tobacco smoke and isolate the individual components responsible
for microbial biofilm induction. However, if the biofilm induction
activity is due to soluble factors of tobacco smoke, the
ramifications of our findings far exceed respiratory infections, as
the vascular system is well equipped to transport such soluble
factors throughout the body. Future work will focus on identifying
a threshold for tobacco induced biofilm formation as well as
identifying the responsible component(s).
Taken together these data support the notion that tobacco
smoke exposure induces biofilm formation in respiratory bacteria
and that smoking cessation should revert bacteria back to a smoke
naı ¨ve phenotype. In vivo this may translate into microbial
community diversity. In support of this, studies have demonstrated
that smoking cessation alters oral/subgingival microbial commu-
nities [43,60]. Fullmer and colleagues demonstrated via terminal
restriction fragment length polymorphism that the subgingival
microbial profiles differed significantly between active smokers and
at 6 and 12 months following smoking cessation [43]. Moreover,
since microbes residing in a biofilm state are known to have
increased resistance to antibiotics, tobacco induced biofilm
formation may contribute to the refractory nature of many
respiratory infections found in smokers.
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